These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria. Laudy AE; Kulińska E; Tyski S Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074 [TBL] [Abstract][Full Text] [Related]
13. Contribution of different mechanisms to the resistance to fluoroquinolones in clinical isolates of Salmonella enterica. Rushdy AA; Mabrouk MI; Abu-Sef FA; Kheiralla ZH; Mohamed Abdel-All S; Saleh NM Braz J Infect Dis; 2013; 17(4):431-7. PubMed ID: 23742803 [TBL] [Abstract][Full Text] [Related]
14. Lack of AcrB Efflux Function Confers Loss of Virulence on Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV mBio; 2017 Jul; 8(4):. PubMed ID: 28720734 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144 [TBL] [Abstract][Full Text] [Related]
16. Role of medicinal plants from North Western Himalayas as an efflux pump inhibitor against MDR AcrAB-TolC Salmonella enterica serovar typhimurium: In vitro and In silico studies. Mehta J; Rolta R; Dev K J Ethnopharmacol; 2022 Jan; 282():114589. PubMed ID: 34492321 [TBL] [Abstract][Full Text] [Related]